Preparation of recombinant proteins in milk to improve human and animal health

Reproduction Nutrition Development

Volumn 46, Issue 5, 2006, Pages 579-588

  Soler, Eric ^a   Thépot, Dominique ^b   Rival Gervier, Sylvie ^b   Jolivet, Geneviève ^b   Houdebine, Louis Marie ^b  

^a BioProtein Technologies   (France)

^b INRA Institut National de la Recherche Agronomique   (France)

Author keywords

Animal and human health; Milk; Recombinant proteins

Indexed keywords

RECOMBINANT PROTEIN;

CONFERENCE PAPER; DRUG MANUFACTURE; GENE EXPRESSION; GENE TRANSFER; HEALTH BEHAVIOR; MASTITIS; MILK; NONHUMAN; NUTRITIONAL VALUE; PROTEIN ANALYSIS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CATTLE; FEMALE; GENE EXPRESSION REGULATION; GENETIC VECTORS; HUMANS; LACTATION; MILK; MILK PROTEINS; NUTRITIVE VALUE; TRANSGENES;

ANIMALIA;

EID: 33750068597     PISSN: 09265287     EISSN: 12979708     Source Type: Journal    
DOI: 10.1051/rnd:2006029     Document Type: Conference Paper

References (49)

1. Houdebine LM, Use of transgenic animals to improve human and health and animal production. Reprod Dom Anim 2005, 40: 269-281.
2. Kuroiwa Y, Kasinathan P, Matsushita H, Sathiyaselan J, Sullivan EJ, Kakitani M, Tomizuka K, Ishida I, Robl JM. Sequential targeting of the genes encoding immunoglobulin-micro and prion protein in cattle. Nature Genet 2004, 36: 671-672.
3. Zhu L, et al. Production of human monoclonal antibody in eggs of chimeric chickens. Nat Biotechnol 2005, 23: 1159-1169.
4. Van de Lavoir MC, Diamond JH, Leighton PA, Mather-Love C, Heyer BS, Bradshaw R, Kerchner A, Hooi LT, Gessaro TM, Swanberg SE, Delany ME, Etches RJ. Germline transmission of genetically modified primordial germ cells. Nature 2006, 441: 766-769.
5. Han JY, Park TS, Lim JM. Chicken pluripotent cells and transgenesis. Transgenic Res 2006, 15: 118.
6. Whitelaw CBA. Transgenic livestock made easy. Trends Biotechnol 2004, 22: 157-160.
7. Whitelaw CB, Radcliffe PA, Ritchie WA, Carlisle A, Ellard FM, Pena RN, Rowe J, Clark AJ, King TJ, Mitrophanous KA. Efficient generation of transgenic pigs using equine infectious anaemia virus (EIAV) derived vector. FEBS Letters 2004, 571: 233-236.
8. Houdebine L, Attal J, Vilotte JL. Vector design for transgene expression. In: Pinkert CA (Ed), Transgenic animal technology, 2nd ed, Academic Press, 2002, p 419-458.
9. Giraldo P, Rival-Gervier S, Houdebine LM, Montoliu L. The potential benefits of insulators on heterologous constructs in transgenic animals. Transgenic Res 2003, 12: 751-755.
10. De Laat W, Grosveld F. Spatial organization of gene expression: the active chromatin hub. Chromosome Res 2003, 11: 447-459.
11. Rival-Gervier S, Viglietta C, Maeder C, Attal J, Houdebine LM. Position-independent and tissue-specific expression of porcine whey acidic protein gene from a bacterial artificial chromosome in transgenic mice. Mol Reprod Dev 2002, 63: 161-167.
12. Zhang XF, Wu GX, Chen JQ, Zhang AM, Liu SG, Jiao BH, Cheng GX. Transfer of an expression YAC into goat fetal fibroblasts by cell fusion for mammary gland bioreactor. Biochim Biophys Res Comm 2005, 333: 58-63.
13. Gong GC, Day YP, Zhu HB, Tang B, Zhao YF, Wang LL, Waang HP, Liu Y, Li R, Hammerström L, LI N. Expression of Lewis a antigen in the milk of cloned calves transferred with human alpha-1,3/4-fucosyltransferase gene. Transgenic Res 2006, 15: 122.
14. Novina CD, Sharp PA. The RNAi revolution. Nature 2004, 430: 161-164.
15. Mittal V. Improving the efficiency of RNA interference in mammals. Nat Rev Genet 2004, 5: 355-365.
16. Zeng Y, Yi R, Cullen BR. MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms. Proc Natl Acad Sci USA 2003, 100: 9779-9784.
17. Bleck GT, White BR, Miller DJ, Wheeler MB. Production of bovine alpha-lactalbumin in the milk of transgenic pigs. J Anim Sci 1998, 76: 3072-3078.
18. Brophy B, Smolenski G, Wheeler T, Wells D, L'Huillier P, Laible G. Cloned transgenic cattle produce milk with higher levels of beta-casein and kappa-casein. Nat Biotechnol 2003, 21: 157-162.
19. Brophy B, Smolenski G, Wells DN, Wheeler TT, Laible G. Increased casien gene dosage and its implicatyion for the composition of milk. Transgenic Res 2006, 15: 123.
20. Vilotte JL. Lowering the milk lactose content in vivo: potential interests, strategies and physiological consequences. Reprod Nutr Dev 2002, 42: 127-132.
21. Jost B, Vilotte JL, Duluc I, Rodeau JL, Freund JN. Production of low-lactose milk by ectopic expression of intestinal lactase in the mouse mammary gland. Nat Biotechnol 1999, 17: 160-164.
22. Reh WA, Maga EA, Collette NMB, Moye A, Conrad-Brink JS, Taylor SJ, DePeters EJ, Oppenheim S, Rowe JD, BonDurant RH, Anderson GB, Murray JD. Hot topics:using a stearoyl-CoA desaturase transgene to alter milk fatty acid composition. J Dairy Sci 2004, 87: 3510-3514.
23. Kao B, Moromoto K, Depeters E, Lewis K, Medrano J, Van Eenennaam. Endogenous production of omega-3 fatty acids in milk. Transgenic Res 2006, 15: 117.
24. Castilla J, Pintado B, Sola I, Sanchez-Morgado JM, Enjuanes L. Engineering passive immunity in transgenic mice secreting virus- neutralizing antibodies in milk. Nat Biotechnol 1998, 16: 349-354.
25. Kolb AF, Pew L, Webster J, Penman S, Whitelaw CB, Siddell SG. Virus neutralizing monoclonal antibody expressed in milk of transgenic mice provides full protection against virus- induced encephalitis. J Virol 2001, 75: 2803-289.
26. Wall RJ, Powell AM, Paape MJ, Kerr DE, Bannerman DD, Pursel VG, Wells KD, Talbot N, Hawk HW. Genetically enhanced cows resist intramammary Staphylococcus aureus infection. Nat Biotechnol 2005, 23: 445-451.
27. Maga E. Properties of milk from human lysozyme transgenic goats. Transgenic Res 2006, 15: 117.
28. Thomassen EA, van Veen HA, van Berkel PH, Nuijens JH, Abrahams JP. The protein structure of recombinant lactoferrin produced in milk of transgenic cows closely matches the structure of human milk-derived lactoferrin. Transgenic Res 2005, 14: 397-405.
29. Baneyx F, Mujacic M. Recombinant protein folding and misfolding in Escherichia coli. Nat Biotechnol 2004, 22: 1399-13408.
30. Hamilton SR, Bobrowicz P, Bobrowicz B, Davidson RC, Li H, Mitchell T, Nett JH, Rausch S, Stadheim TA, Wischnewski H, Wildt S, Gerngross TU. Production of complex human glycoproteins in yeast. Science 2003, 301: 1244-1246.
31. Massoud M, Bischoff R, Dalemans W, Pointu H, Altal J, Schultz H, Clesse D, Stinnakre MG, Pavirani A, Houdebine LM. Expression of active recombinant human alpha 1-antitrypsin in transgenic rabbits. J Biotechnol 1991, 18: 193-203.
32. Houdebine LM. Antibody manufacture in transgenic animals and comparisons with other systems. Curr Opin Biotechnol 2002, 13: 625-629.
33. Koles K, van Berkel PH, Pieper FR, Nuijens JH, Mannesse ML, Vliegenthart JF, Kamerling JP. N- and O-glycans of recombinant human C1 inhibitor expressed in the milk of transgenic rabbits. Glycobiology 2004, 14: 51-64.
34. Soler E, Le Saux A, Guinut F, Passet B, Cohen R, Merle C, Charpilienne A, Fourgeux C, Sorel V, Piriou A, Schwartz-Cornil I, Cohen J, Houdebine LM. Production of two vaccinating recombinant rotavirus proteins in the milk of transgenic rabbits. Transgenic Res 2005, 14: 833-844.
35. Soler E, Le Saux A, Guinut F, Passet B, Cohen R, Merle C, Charpilienne A, Fourgeux C, Sorel V, Piriou A, Schwartz-Cornil I, Cohen J, Houdebine LM. Transgenic Animal Research, Conference V, Tahoe City, USA. Transgenic Res 2006, 15: 120.
36. Lubon H. Transgenic animal bioreactors in biotechnology and production of blood proteins. Biotechnol Annu 1998, 4: 1-54.
37. Edmunds T, Van Patten SM, Pollock J, Hanson E, Bernasconi R, Higgins E, Manavalan P, Ziomek C, Meade H, McPherson J, Cole ES. Transgenically produced human antithrombin: structural and functional comparison to human plasma-derived antithrombin. Blood 2005, 91: 4561-4571.
38. Shinkawa T, Nakamura K, Yamane N, Shoji-Hosaka E, Kanda Y, Sakurada M, Uchida K, Anazawa H, Satoh M, Yamasaki M, Hanai N, Shitara K. The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J Biol Chem 2003, 278: 3466-3473.
39. Stomqvist M, Houdebine LM, Andersson JO, Edlund A, Johansson T, Viglietta C, Puissant C, Hansson L. Recombinant human superoxide dismutase produced in milk of transgenic rabbits. Transgenic Res 1997, 6: 271-278.
40. Stowers AW, Chen Lh LH, Zhang Y, Kennedy MC, Zou L, Lambert L, Rice TJ, Kaslow DC, Saul A, Long CA, Meade H, Miller LH. A recombinant vaccine expressed in the milk of transgenic mice protects Aotus monkeys from a lethal challenge with Plasmodium falciparum. Proc Natl Acad Sci USA 2002, 99: 339-344.
41. Gomord V, Chamberlain P, Jefferis R, Paye L. Biopharmaceutical production in plants: problems, solutions and opportunities. Trends Biotechnol 2005, 23: 559-565.
42. Kirk DD, McIntosh K, Walmsley AM, Peterson RK. Risk analysis for plant-made vaccines. Transgenic Res 2005, 14: 449-462.
43. Leon-Banares R, Gonzalez-Ballester D, Galvan A, Fernandez E. Transgenic microalgae as green cell-factories. Trends Biotechnol 2004, 22: 45-52.
44. Hellwig S, Drossard J, Twyman RM, Fischer R. Plant cell cultures for the production of recombinant proteins. Nat Biotechnol 2004, 22: 1415-1422.
45. Thiel KA. Biomanufacturing from bust to boom... to bubble? Nat Biotechnol 2004, 22: 1365-1372.
46. Birse D, Lacroix D, Dyck M, Pothier F, Sirard MA. Biotherapeutics from transgenic porcine sources: bioprocessing approaches and challenges. Bioprocessing J 2004, 4: 1-8.
47. Royer C, Jalabert A, Da Rocha M, Grenier AM, Mauchamp B, Couble P, Chavancy G. Biosynthesis and cocoon-export of a recombinant globular protein in transgenic silkworms. Transgenic Res 2005, 14: 463-472.
48. Sanchez O, Toledo JR, Rodriguez MP, Castro FO. Adenoviral vector mediates high expression levels of human growth hormone in the milk of mice and goat. J Biotechnol 2004, 114: 89-97.
49. Walsh G. Biopharmaceutical benchmark. Nat Biotechnol 2003, 21: 865-870.